In the present study, we endeavor to ascertain the expression pattern of CD80 in FLT3-ITD+ AML cells and disclose the molecular underpinnings by which FLT3-ITD drives the upregulation of CD80. This evidence concerns the gene FLT3 and acute myeloid leukemia.